Iovance Biotherapeutics, Inc. - Common Stock — Bilan (NASDAQ:IOVA)

Afficher le graphique complet Full chart

Financials

Total de l'actif 768.46 M777.33 M663.98 M780.35 M910.43 M913.17 M Total du passif 111.96 M155.67 M164.34 M195.74 M200.02 M214.59 M Total des capitaux propres 656.5 M621.66 M499.64 M584.61 M710.4 M698.58 M Total du passif et des capitaux propres 768.46 M777.33 M663.98 M780.35 M910.43 M913.17 M Dette totale —1 M1 M1 M1 M— Dette nette —-503.41 M-470.85 M-278.87 M-322.78 M—

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

IOVA

Financials

Iovance Biotherapeutics, Inc. - Common Stock

Nouvelles

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio: Anktiva Explained and What Comes Next

AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential?

La vente à découvert d’Intellia progresse le plus parmi les biotechs

IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

Undercovered Stocks: Western Digital, SAP, Toast And More

Pacira (PCRX) Q1 Earnings Miss Estimates

Iovance Biotherapeutics (IOVA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Regeneron (REGN) Surpasses Q1 Earnings and Revenue Estimates